AstraZeneca / BenevolentAI artificial intelligence collaboration will accelerate drug discovery Potential new drugs discovery in the area of chronic kidney disease and idiopathic pulmonary fibrosis (PRESS RELEASE) CAMBRIDGE / LONDON, 30-Apr-2019 — /EuropaWire/ — New partnership, announced today, by AstraZeneca … Read the full press release →
Posted in Healthcare, News, Pharma & Biotech, Science, Technology, United Kingdom
Tagged AI, AI discovery platform, artificial-intelligence, AstraZeneca, Benevolent Platform, BenevolentAI, biomedical knowledge graph, chemistry, Christina Malmberg Hägerstrand, Chronic kidney disease, CKD, clinical data, disease biology, genomics, Gonzalo Viña, idiopathic pulmonary fibrosis, IPF, Jennifer Hursit, Joanna Shields, Machine Learning, Matt Kent, Mene Pangalos, Michele Meixell, pathophysiology of disease, Rebecca Einhorn, Rob Skelding
| M | T | W | T | F | S | S |
|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | ||
| 6 | 7 | 8 | 9 | 10 | 11 | 12 |
| 13 | 14 | 15 | 16 | 17 | 18 | 19 |
| 20 | 21 | 22 | 23 | 24 | 25 | 26 |
| 27 | 28 | 29 | 30 | 31 | ||
